Clinuvel Pharmaceuticals Statistics

Total Valuation

ASX:CUV has a market cap or net worth of AUD 618.98 million. The enterprise value is 395.40 million.

Market Cap	618.98M
Enterprise Value	395.40M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	Sep 4, 2025

Share Statistics

ASX:CUV has 50.20 million shares outstanding. The number of shares has decreased by -1.27% in one year.

Current Share Class	50.20M
Shares Outstanding	50.20M
Shares Change (YoY)	-1.27%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	10.26%
Owned by Institutions (%)	20.97%
Float	41.56M

Valuation Ratios

The trailing PE ratio is 17.17 and the forward PE ratio is 16.65. ASX:CUV's PEG ratio is 2.25.

PE Ratio	17.17
Forward PE	16.65
PS Ratio	6.51
PB Ratio	2.57
P/TBV Ratio	2.57
P/FCF Ratio	15.17
P/OCF Ratio	15.06
PEG Ratio	2.25

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.43, with an EV/FCF ratio of 9.69.

EV / Earnings	10.93
EV / Sales	4.16
EV / EBITDA	8.43
EV / EBIT	8.64
EV / FCF	9.69

Financial Position

The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.

Current Ratio	9.66
Quick Ratio	9.25
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	10.25

Financial Efficiency

Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 12.85%.

Return on Equity (ROE)	16.30%
Return on Assets (ROA)	11.37%
Return on Invested Capital (ROIC)	12.85%
Return on Capital Employed (ROCE)	18.71%
Revenue Per Employee	5.94M
Profits Per Employee	2.26M
Employee Count	16
Asset Turnover	0.38
Inventory Turnover	0.87

Taxes

In the past 12 months, ASX:CUV has paid 15.38 million in taxes.

Income Tax	15.38M
Effective Tax Rate	29.83%

Stock Price Statistics

The stock price has decreased by -4.86% in the last 52 weeks. The beta is 0.92, so ASX:CUV's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-4.86%
50-Day Moving Average	11.58
200-Day Moving Average	11.29
Relative Strength Index (RSI)	69.47
Average Volume (20 Days)	86,517

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CUV had revenue of AUD 95.02 million and earned 36.17 million in profits. Earnings per share was 0.72.

Revenue	95.02M
Gross Profit	86.54M
Operating Income	45.76M
Pretax Income	51.55M
Net Income	36.17M
EBITDA	46.54M
EBIT	45.76M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 224.11 million in cash and 528,528 in debt, giving a net cash position of 223.58 million or 4.45 per share.

Cash & Cash Equivalents	224.11M
Total Debt	528,528
Net Cash	223.58M
Net Cash Per Share	4.45
Equity (Book Value)	240.81M
Book Value Per Share	4.80
Working Capital	235.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 41.10 million and capital expenditures -298,567, giving a free cash flow of 40.80 million.

Operating Cash Flow	41.10M
Capital Expenditures	-298,567
Free Cash Flow	40.80M
FCF Per Share	0.81

Full Cash Flow Statement

Margins

Gross margin is 91.08%, with operating and profit margins of 48.16% and 38.07%.

Gross Margin	91.08%
Operating Margin	48.16%
Pretax Margin	54.26%
Profit Margin	38.07%
EBITDA Margin	48.98%
EBIT Margin	48.16%
FCF Margin	42.94%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.41%.

Dividend Per Share	0.05
Dividend Yield	0.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.92%
Buyback Yield	1.27%
Shareholder Yield	1.68%
Earnings Yield	5.84%
FCF Yield	6.59%

Dividend Details

Stock Splits

The last stock split was on November 12, 2010. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 12, 2010
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:CUV has an Altman Z-Score of 14.53 and a Piotroski F-Score of 5.

Altman Z-Score	14.53
Piotroski F-Score	5